Does Abciximab Promote Coronary Artery Remodeling in Patients With Kawasaki Disease?

Standard therapy, consisting of intravenous immunoglobulin and aspirin, reduces, but does not eliminate, coronary artery aneurysms (CAAs) in patients with Kawasaki disease. Large CAAs can persist or undergo varying degrees of regression. The treatment of large CAAs using abciximab has been associate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2010-06, Vol.105 (11), p.1625-1628
Hauptverfasser:	McCandless, Rachel T., MD, Minich, L. LuAnn, MD, Tani, Lloyd Y., MD, Williams, Richard V., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - therapeutic use Aspirin Aspirin - therapeutic use Biological and medical sciences Cardiology. Vascular system Cardiovascular Cardiovascular disease Child Child, Preschool Coronary vessels Coronary Vessels - diagnostic imaging Coronary Vessels - pathology Drug Therapy, Combination Female Follow-Up Studies Humans Immunoglobulin Fab Fragments - therapeutic use Immunoglobulins Immunoglobulins - therapeutic use Infant Male Medical diagnosis Medical Records Medical sciences Mucocutaneous Lymph Node Syndrome - diagnostic imaging Mucocutaneous Lymph Node Syndrome - drug therapy Mucocutaneous Lymph Node Syndrome - pathology Platelet Aggregation Inhibitors - therapeutic use Regression analysis Retrospective Studies Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Therapy Treatment Outcome Ultrasonography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!